The use of the Liverpool University neuroleptic side‐effect rating scale (LUNSERS) in clinical practice
摘要:
ABSTRACTForty‐four mental health clients completed the Liverpool University Neuroleptic Side‐Effect Rating Scale (LUNSERS)—a self‐rating scale to assess the prevalence and intensity of neuroleptic side‐effects. In the month prior to the study, 50% of the clients surveyed had experienced more than half of the side‐effects outlined on the 41‐item scale. A prevalence profile allowed us to rank the frequency of individual side‐effects across the sample. Some side‐effects such as ‘difficulty concentrating’, ‘difficulty remembering’, ‘tiredness’ and ‘restlessness’ were experienced by most of the clients in the study while ‘unusual skin marks’, ‘difficulty passing water’, ‘rashes’ were experienced by a few. A prevalence profile may be a useful guide in developing strategies for managing side‐effects more effectively in small groups of clients. In addition, the use of the LUNSERS in clinical practice would enable case managers to establish baseline measures for individual clients and evaluate changes in medication and other non‐medical strategies for reducing unwanted side‐effects. The identification and assessment of antipsychotic side‐effects is an important area for client and professional carer education.
[EN] HYDROXY AND ALKOXY COUMARINS AS MODULATORS OF POLRMT [FR] HYDROXYCOUMARINES ET ALCOXYCOUMARINES UTILES COMME MODULATEURS DE POLRMT
摘要:
The present invention provides novel hydroxy and alkoxy coumarin compounds that are inhibitors of mitochondrial RNA polymerase for treating various diseases such as cancer and others associated with metabolic disorders and mitochondrial dysfunction.
[EN] NEW CONTRAST AGENT FOR USE IN MAGNETIC RESONANCE IMAGING<br/>[FR] NOUVEL AGENT DE CONTRASTE DESTINÉ À ÊTRE UTILISÉ DANS L'IMAGERIE PAR RÉSONANCE MAGNÉTIQUE
申请人:BAYER AG
公开号:WO2022194777A1
公开(公告)日:2022-09-22
The present invention relates to a new class of compounds of general formula (I), the Gd3+chelate complexes thereof, to methods of preparing said compounds, and to the use of said compounds as MRI contrast agents. Formula (I)
The development of efficient and stereoselective methods to produce 1,4-disubstituted-2-oxopiperazine in enantiomerically pure form, from a readily available starting material is crucial. Herein, we report a reduction modification to our previously described synthesis of 1,4-disubstituted-2-oxopiperazine and also two original shortly accessed pathways. These new pathways can be routinely performed on a multigram scale and should rapidly find a place in the preparation of the 3-substituted-2-oxopiperazine diastereomers. Stereoselective alkylation of 1,4-disubstituted-2-oxopiperazine led to the corresponding (3S)-diastereomer or (3R)-diastereomer from the corresponding 2-oxopiperazine enantiomer with the chiral inductor substituted at the N-1 (1*) position, respectively, in good yield. (C) 2008 Elsevier Ltd. All rights reserved.
The Effect of Cesium Fluoride-DMF in the Dibutylstannylene Acetal-Mediated Selective Monobenzylation of Methyl 2,3-D-Glycerate.